ストックスクリーナーアプリを入手
0.9135
2.78%
0.0247
プレマーケット:
.90
-0.0135
-1.48%
前日終値:
$0.8888
開ける：
$0.87
24時間の取引高:
1.23M
Relative Volume:
0.16
時価総額：
$53.42M
収益：
$950.10K
当期純損益:
$-16.69M
株価収益率:
-1.1006
EPS:
-0.83
ネットキャッシュフロー:
$-15.16M
1週間 パフォーマンス:
-7.77%
1か月 パフォーマンス:
+33.65%
6か月 パフォーマンス:
+14.19%
1年 パフォーマンス:
-17.70%
1日の値動き範囲:
$0.87
$0.9582
1週間の範囲:
$0.83
$1.03
52週間の値動き範囲:
$0.3067
$1.80
Femasys Inc Stock (FEMY) Company Profile
FEMY を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
FEMY
Femasys Inc
|
0.9135 | 51.98M | 950.10K | -16.69M | -15.16M | -0.83 |
|
ISRG
Intuitive Surgical Inc
|
568.65 | 201.96B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
193.76 | 55.25B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
78.99 | 39.31B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
251.51 | 36.70B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
WST
West Pharmaceutical Services Inc
|
281.77 | 20.45B | 2.96B | 487.70M | 344.00M | 6.6758 |
Femasys Inc Stock (FEMY) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-11-20 | 開始されました | Laidlaw | Buy |
Femasys Inc (FEMY) 最新ニュース
Femasys Inc Stock Analysis and ForecastTechnical Breakout Signals & Minimal Capital Trading - earlytimes.in
PMCB Stock Jumps 25% After Company Sells Stake In Femasys - MSN
CapEx per share of Femasys Inc. – NASDAQ:FEMY - TradingView
PharmaCyte Biotech stock surges following profitable exit from Femasys investment - MSN
Why Femasys Inc. stock is a must watch in 20252025 Earnings Impact & High Return Trade Guides - BỘ NỘI VỤ
PharmaCyte Biotech sells Femasys stake, boosts cash position to $20 million - Investing.com Nigeria
PharmaCyte Biotech stock soars after successful Femasys stake sale By Investing.com - Investing.com Australia
PharmaCyte Biotech stock soars after successful Femasys stake sale - Investing.com
PharmaCyte Biotech Successfully Monetizes Femasys Stake, Strengthening Cash Position and Underscoring Strategic Capital Deployment - Lelezard
PharmaCyte Biotech sells Femasys stake, boosts cash position to $20 million By Investing.com - Investing.com South Africa
PharmaCyte Biotech (Nasdaq: PMCB) Now Holds ~$20M Cash, $25M in Marketable Securities - Stock Titan
Femasys Inc. (FEMY) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Femasys (FEMY) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Laidlaw initiates Femasys stock with Buy rating on FemaSeed potential By Investing.com - Investing.com South Africa
Femasys initiated with a Buy at Laidlaw - TipRanks
Why retail investors pile into Femasys Inc. stockJuly 2025 Intraday Action & AI Enhanced Market Trend Forecasts - newser.com
Is Femasys Inc. stock oversold or undervaluedJuly 2025 PreEarnings & Real-Time Volume Trigger Notifications - newser.com
Laidlaw initiates Femasys stock with Buy rating on FemaSeed potential - Investing.com
Is Femasys Inc. stock attractive for growth ETFsEarnings Summary Report & Safe Capital Growth Stock Tips - newser.com
What margin trends mean for Femasys Inc. stockRate Hike & Fast Exit Strategy with Risk Control - newser.com
Is Femasys Inc. stock affected by interest rate hikesInsider Buying & Verified Entry Point Detection - newser.com
[Form 4] FEMASYS INC Insider Trading Activity - Stock Titan
Applying Elliott Wave Theory to Femasys Inc.2025 Geopolitical Influence & Fast Entry Momentum Alerts - newser.com
Femasys: Strategic Advancements and Financial Health Justify Buy Rating - TipRanks
MSN Money - MSN
Can Femasys Inc. stock reach $100 price targetMarket Risk Analysis & Free Fast Gain Swing Trade Alerts - newser.com
Is Femasys Inc. trending in predictive chart modelsJuly 2025 Levels & Weekly High Momentum Picks - newser.com
Custom watchlist performance reports with Femasys Inc.Earnings Growth Summary & Daily Entry Point Trade Alerts - newser.com
Is Femasys Inc. stock a safe haven assetMarket Performance Report & Reliable Entry Point Alerts - newser.com
Femasys Inc. (FEMY) Reports Q1 Loss, Misses Revenue Estimates - MSN
Will Femasys Inc. stock continue upward momentumPortfolio Risk Report & Weekly High Potential Stock Alerts - newser.com
Femasys Inc (FEMY) 財務データ
収益
当期純利益
現金流量
EPS
2.17%
0.89%
大文字化:
|
ボリューム (24 時間):